# WOK (WORK Medical Technology Group LTD) - SEC EDGAR Financial Statements

> WORK Medical Technology Group LTD reported $9.85M in revenue and a net loss of $1.07M for the fiscal year ended September 30, 2025 (down 14.4% year over year), with a 23.8% gross margin and a -25.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/WOK
- Markdown: https://convexityos.com/fundamentals/WOK.md
- SEC CIK: 0001929783
- Reporting currency: USD
- Latest filing period: September 30, 2025
- Last synced: Nov 21, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001929783&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $9.85M | -14.4% YoY |
| Operating Income | FY 2025 | -$2.50M | -25.3% margin |
| Net Income | FY 2025 | -$1.07M | -10.9% net margin |
| Diluted EPS | FY 2025 | -$0.04 | Split-adjusted |
| Free Cash Flow | FY 2025 | $4.91M | 49.9% FCF margin |
| Cash & ST Investments | Sep 30, 2025 | $4.09M | Total debt: $6.42M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $9.85M | $11.51M | $13.57M | $19.71M |
| **Gross Profit** | $2.34M | $2.87M | $4.14M | $4.42M |
| Research & Development | $435K | $303K | $302K | $184K |
| Selling, General & Admin | $4.41M | $6.61M | $3.43M | $3.60M |
| Total Operating Expenses | $4.84M | $6.91M | $3.73M | $3.78M |
| **Operating Income** | -$2.50M | -$4.05M | $412K | $638K |
| **EBITDA** | -$1.57M | -$2.63M | $2.02M | $3.90M |
| Interest Income | $182K | $12K | $25K | $2.0K |
| Interest Expense | $504K | $558K | $393K | $353K |
| Income Before Tax | -$1.08M | -$3.67M | $110K | $1.11M |
| Income Tax Expense | $119K | -$125K | $47K | $169K |
| **Net Income** | -$1.07M | -$3.49M | $112K | $865K |
| Basic EPS | -$0.04 | -$0.27 | $0.01 | $0.07 |
| **Diluted EPS** | -$0.04 | -$0.27 | $0.01 | $0.07 |
| Basic Shares Outstanding | 29.0M | 12.7M | 12.5M | 12.5M |
| Diluted Shares Outstanding | 29.0M | 12.7M | 12.5M | 12.5M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.09M | $6.56M | $1.60M |
| **Cash & Short-Term Investments** | $4.09M | $6.56M | $1.60M |
| Accounts Receivable, Net | $616K | $1.65M | $3.33M |
| Inventory | $2.46M | $3.18M | $4.62M |
| **Total Current Assets** | $20.46M | $20.83M | $22.15M |
| Property, Plant & Equipment, Net | $10.59M | $11.37M | $6.63M |
| Intangible Assets | $959K | $1.04M | $998K |
| **Total Non-Current Assets** | $12.70M | $15.42M | $7.81M |
| **Total Assets** | $33.16M | $36.25M | $29.96M |
| Accounts Payable | $1.72M | $1.50M | $3.96M |
| Short-Term Debt | $6.39M | $13.32M | $8.84M |
| Deferred Revenue (Current) | $402K | $625K | $776K |
| Other Current Liabilities | -- | $1.22M | $160K |
| **Total Current Liabilities** | $11.97M | $20.18M | $18.92M |
| **Total Non-Current Liabilities** | $20K | $0 | $50K |
| **Total Liabilities** | $11.99M | $20.18M | $18.97M |
| **Total Debt (incl. Leases)** | $6.42M | $13.32M | $8.94M |
| Common Stock | -- | $7.3K | $6.2K |
| Retained Earnings | $4.96M | $6.08M | $9.58M |
| Accumulated Other Comp. Income | -$609K | -$408K | -$677K |
| **Total Stockholders' Equity** | $18.34M | $13.19M | $9.88M |
| Total Equity | $21.16M | $16.07M | $10.99M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2025 | Sep 2024 | Sep 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.09M | $6.56M | $1.60M |
| **Cash & Short-Term Investments** | $4.09M | $6.56M | $1.60M |
| Accounts Receivable, Net | $616K | $1.65M | $3.33M |
| Inventory | $2.46M | $3.18M | $4.62M |
| **Total Current Assets** | $20.46M | $20.83M | $22.15M |
| Property, Plant & Equipment, Net | $10.59M | $11.37M | $6.63M |
| Intangible Assets | $959K | $1.04M | $998K |
| **Total Non-Current Assets** | $12.70M | $15.42M | $7.81M |
| **Total Assets** | $33.16M | $36.25M | $29.96M |
| Accounts Payable | $1.72M | $1.50M | $3.96M |
| Short-Term Debt | $6.39M | $13.32M | $8.84M |
| Deferred Revenue (Current) | $402K | $625K | $776K |
| Other Current Liabilities | -- | $1.22M | $160K |
| **Total Current Liabilities** | $11.97M | $20.18M | $18.92M |
| **Total Non-Current Liabilities** | $20K | $0 | $50K |
| **Total Liabilities** | $11.99M | $20.18M | $18.97M |
| **Total Debt (incl. Leases)** | $6.42M | $13.32M | $8.94M |
| Common Stock | -- | $7.3K | $6.2K |
| Retained Earnings | $4.96M | $6.08M | $9.58M |
| Accumulated Other Comp. Income | -$609K | -$408K | -$677K |
| **Total Stockholders' Equity** | $18.34M | $13.19M | $9.88M |
| Total Equity | $21.16M | $16.07M | $10.99M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$1.20M | -$3.54M | $63K | $944K |
| Depreciation & Amortization | $923K | $1.41M | $1.60M | $3.26M |
| Change in Receivables | $1.02M | $1.82M | -$132K | -$4.23M |
| Change in Inventory | $569K | $1.58M | -$401K | $2.05M |
| Change in Payables | $245K | -$2.55M | $865K | -$5.82M |
| **Operating Cash Flow** | $6.24M | -$2.23M | $2.21M | -$2.26M |
| Capital Expenditure | -$1.33M | -$9.23M | -$455K | -$2.01M |
| **Free Cash Flow** | $4.91M | -$11.45M | $1.75M | -$4.27M |
| **Investing Cash Flow** | -$7.61M | -$9.06M | -$583K | -$1.35M |
| **Financing Cash Flow** | -$898K | $15.66M | -$729K | $3.57M |
| **Net Change in Cash** | -$2.47M | $4.92M | $864K | -$100K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 23.8% | 24.9% | 30.5% | 22.4% |
| **Operating Margin** | -25.3% | -35.2% | 3.0% | 3.2% |
| **Net Profit Margin** | -10.9% | -30.4% | 0.8% | 4.4% |
| Return on Equity (ROE) | -5.8% | -26.5% | 1.1% | -- |
| Return on Assets (ROA) | -3.2% | -9.6% | 0.4% | -- |
| Current Ratio | 1.71x | 1.03x | 1.17x | -- |
| Quick Ratio | 1.50x | 0.87x | 0.93x | -- |
| Debt to Equity | 0.35x | 1.01x | 0.91x | -- |
| **Revenue Growth (YoY)** | -14.4% | -15.2% | -31.2% | -- |
| Gross Profit Growth (YoY) | -18.3% | -30.8% | -6.2% | -- |
| Operating Income Growth (YoY) | -- | -1081.3% | -35.4% | -- |
| **Net Income Growth (YoY)** | -- | -3217.3% | -87.1% | -- |
| EPS Growth (YoY) | -- | -2800.0% | -85.7% | -- |
| Operating Cash Flow Growth (YoY) | -- | -200.8% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -752.8% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
